Kinetics of medium-chain triglycerides and free fatty acids in healthy volunteers and surgically stressed patients.

To determine the hydrolysis rate of medium-chain triglycerides (MCTs) to medium-chain free fatty acids (MCFAs) and the disposition rate of MCFAs, five healthy volunteers (H) and eight surgically stressed patients (S) received 0.5 mL of Lipofundin 20% per kilogram body weight as an intravenous bolus. Serum MCTs (C8 and C10) and MCFAs were measured by high-performance liquid chromatography during the 120 minutes postinjection. A linear two-compartment model was found to be descriptive and robust: the apparent volumes of distribution were found to be similar in healthy and surgical subjects for both MCTs and MCFAs. The first-order transformation rate constant (hydrolysis) from MCTs to MCFAs was not significantly different between the H and S groups (overall 0.112 +/- 0.022/min, C8; 0.078 +/- 0.020/min, C10). The rate constant for tissue MCFA uptake from plasma was significantly different between S and H subjects both for C10 alone (H: 0.0337 +/- 0.0078; S: 0.1194 +/- 0.0240; p = .020) and for C8 and C10 together (H: 0.0382 +/- 0.0054; S: 0.1012 +/- 0.0168; p = .008), whereas it failed to attain significance when C8 alone was considered (H: 0.047 +/- 0.0077; S: 0.0829 +/- 0.0230; p = .210). These results show that use of MCTs is increased in surgical patients because of enhanced tissue uptake of the corresponding free fatty acids, whereas there does not seem to be an increase of MCT hydrolysis in response to acute disease. This would indicate that the stressed patient is in fact able to effectively use this alternative lipid substrate in the face of increased metabolic demand.

[1]  W. Leonhardt,et al.  Elimination and metabolism of a fat emulsion containing medium chain triglycerides (lipofundin MCT 10%). , 1988, JPEN. Journal of parenteral and enteral nutrition.

[2]  J. Rabinowitz,et al.  A method for serum octanoate in hepatic cirrhosis and hepatic encephalopathy. , 1977, Clinical chemistry.

[3]  H. Mehnert,et al.  Comparison of metabolic clearance rates of MCT/LCT and LCT emulsions in diabetics. , 1988, JPEN. Journal of parenteral and enteral nutrition.

[4]  T. Lavé,et al.  Activities of lipoprotein lipase and hepatic lipase on long- and medium-chain triglyceride emulsions used in parenteral nutrition. , 1989, Metabolism: Clinical and Experimental.

[5]  G. Blackburn,et al.  Alternative lipid sources for enteral and parenteral nutrition: long- and medium-chain triglycerides, structured triglycerides, and fish oils. , 1991, Journal of the American Dietetic Association.

[6]  G. Blackburn,et al.  Thermogenesis from intravenous medium-chain triglycerides. , 1991, JPEN. Journal of parenteral and enteral nutrition.

[7]  N. Baba,et al.  Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. , 1982, The American journal of clinical nutrition.

[8]  A. Bach,et al.  Medium-chain triglycerides: an update. , 1982, The American journal of clinical nutrition.

[9]  R. Cotter,et al.  A metabolic comparison of a pure long-chain triglyceride lipid emulsion (LCT) and various medium-chain triglyceride (MCT)-LCT combination emulsions in dogs. , 1987, The American journal of clinical nutrition.

[10]  A. Dennison,et al.  A new intravenous emulsion containing medium-chain triglyceride: studies of its metabolic effects in the perioperative period compared with a conventional long-chain triglyceride emulsion. , 1985, JPEN. Journal of parenteral and enteral nutrition.

[11]  L. Hands,et al.  Use of a lipid containing medium chain triglycerides in patients receiving TPN: A randomized prospective trial , 1987, The British journal of surgery.

[12]  W. Leonhardt,et al.  Elimination kinetics of Lipofundin MCT: bolus injection and infusion compared. , 1987, JPEN. Journal of parenteral and enteral nutrition.

[13]  A. Bach Les triglycérides à chaînes moyennes , 1975 .

[14]  J. Strong,et al.  Fatty acid composition of adipose tissue in humans: differences between subcutaneous sites. , 1989, The American journal of clinical nutrition.

[15]  A. Bach,et al.  Metabolic effects of medium- or long-chain triglycerides and high-protein, carbohydrate-free diets in Zucker rats. , 1984, Metabolism: clinical and experimental.

[16]  J. Guilland,et al.  Fatty acid composition of serum lipids and its relation to diet in an elderly institutionalized population. , 1988, The American journal of clinical nutrition.

[17]  D. Sailer,et al.  Effect of fat emulsions containing medium-chain triglycerides and glucose on ketone body production and excretion. , 1984, JPEN. Journal of parenteral and enteral nutrition.

[18]  J. Kinney,et al.  Intravenous infusion of a medium-chain triglyceride-enriched lipid emulsion. , 1988, Critical care medicine.

[19]  C. Metges,et al.  Medium- and long-chain triglycerides labeled with 13C: a comparison of oxidation after oral or parenteral administration in humans. , 1991, The Journal of nutrition.

[20]  A. Bach,et al.  Effects of medium- and long-chain triacylglycerols on adipose tissue metabolism in the obese Zucker rat. , 1983, International journal of obesity.

[21]  D. Sailer,et al.  Medium chain triglycerides in parenteral nutrition. , 1981, JPEN. Journal of parenteral and enteral nutrition.

[22]  C. Pichard,et al.  Comparative clearance of two new fat emulsions--Hausmann Lipid 20% and Lipovenös 20%--versus intralipid 20%. , 1990, JPEN. Journal of parenteral and enteral nutrition.

[23]  A. Geliebter,et al.  Overfeeding with medium-chain triglyceride diet results in diminished deposition of fat. , 1983, The American journal of clinical nutrition.

[24]  R. Cotter,et al.  Medium-chain-triglyceride lipid emulsion: metabolism and tissue distribution. , 1990, The American journal of clinical nutrition.

[25]  J D Laird,et al.  Mechanics of resting isolated single vascular smooth muscle cells from bovine coronary artery. , 1984, The American journal of physiology.

[26]  J. Senior,et al.  5. Hepatic Metabolism of Medium Chain Fatty Acids , 1968 .

[27]  F. Schildberg,et al.  [Elimination and metabolism of MCT-containing fat emulsions in postoperative patients in the framework of total parenteral nutrition]. , 1990, Infusionstherapie.

[28]  M. Ball,et al.  Intravenous feeding with medium chain triglycerides. Effect on blood gases and the complement system in critically ill patients , 1986, Anaesthesia.

[29]  L. Hands,et al.  The metabolic consequences of infusing emulsions containing medium chain triglycerides for parenteral nutrition: a comparative study with conventional lipid. , 1986, Annals of the Royal College of Surgeons of England.

[30]  Y. Hiramatsu,et al.  Effect of medium-chain triglycerides (MCT) as an energy substrate after hepatectomy in rats with streptozotocin-induced diabetes , 1990, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[31]  J. McGarry,et al.  Regulation of hepatic fatty acid oxidation and ketone body production. , 1980, Annual review of biochemistry.

[32]  M. Adolph,et al.  Verteilung und Elimination mittel- und langkettiger Fettsäuren einer Fettemulsion in den Lipoproteinen schwerverletzter Patienten nach Bolusinjektion , 1989 .